Haffkine Bio Pharmaceutical Corporation Limited — Vaccine Exporter Profile
Indian Pharmaceutical Exporter · #8 for Vaccine · $3.3M export value · DGFT Verified
Haffkine Bio Pharmaceutical Corporation Limited is the #8 Indian exporter of Vaccine with $3.3M in export value and 66 verified shipments. Haffkine Bio Pharmaceutical Corporation Limited holds a 0.5% market share in Vaccine exports across 21 countries.
Haffkine Bio Pharmaceutical Corporation Limited — Vaccine Export Profile: Buyers & Destinations
Where Does Haffkine Bio Pharmaceutical Corporation Limited Export Vaccine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SUDAN | $544.5K | 13 | 19.9% |
| AFGHANISTAN | $500.0K | 10 | 18.3% |
| MALAWI | $200.0K | 4 | 7.3% |
| KENYA | $200.0K | 4 | 7.3% |
| SYRIA | $187.3K | 5 | 6.9% |
| RWANDA | $150.0K | 3 | 5.5% |
| MADAGASCAR | $150.0K | 3 | 5.5% |
| TAJIKISTAN | $150.0K | 3 | 5.5% |
| NIGER | $100.0K | 2 | 3.7% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $100.0K | 2 | 3.7% |
Haffkine Bio Pharmaceutical Corporation Limited exports Vaccine to 21 countries. The largest destination is SUDAN accounting for 19.9% of Haffkine Bio Pharmaceutical Corporation Limited's Vaccine shipments, followed by AFGHANISTAN (18.3%) and MALAWI (7.3%). These destinations reflect Haffkine Bio Pharmaceutical Corporation Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vaccine from Haffkine Bio Pharmaceutical Corporation Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GENERAL DIRECTORATE OF GLOBAL HEALT | SUDAN | $544.3K | 12 |
| UNICEF KABUL SUPPLY LOGISTICS | AFGHANISTAN | $250.0K | 5 |
| MINISTRY OF HEALTH | IRAQ | $200.0K | 4 |
| UNICEF SOMALIA SUPPORT CENTER | KENYA | $200.0K | 4 |
| MINISTRY OF HEALTH, | MALAWI | $150.0K | 3 |
| UNICEF MADAGASCAR | MADAGASCAR | $150.0K | 3 |
| REPUBLICAN CENTRE OF IMMUNO PROPHYL | TAJIKISTAN | $150.0K | 3 |
| UNICEF KABUL SUPPLY & LOGISTICS | AFGHANISTAN | $150.0K | 3 |
| UNITED NATIONS CHILDREN'S FUND. | SYRIA | $100.0K | 2 |
| UNICEF KABUL SUPPLY & LOGISTICS, | AFGHANISTAN | $100.0K | 2 |
Haffkine Bio Pharmaceutical Corporation Limited supplies Vaccine to 29 buyers globally. The largest buyer is GENERAL DIRECTORATE OF GLOBAL HEALT (SUDAN), followed by UNICEF KABUL SUPPLY LOGISTICS (AFGHANISTAN) and MINISTRY OF HEALTH (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vaccine Export Value and How Much Does Haffkine Bio Pharmaceutical Corporation Limited Contribute?
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Haffkine Bio Pharmaceutical Corporation Limited contributes $3.3M to this total, accounting for 0.5% of India's Vaccine exports. Haffkine Bio Pharmaceutical Corporation Limited ships Vaccine to 21 countries through 29 buyers.
What Is the Average Shipment Value for Haffkine Bio Pharmaceutical Corporation Limited's Vaccine Exports?
Haffkine Bio Pharmaceutical Corporation Limited's average Vaccine shipment value is $50.0K per consignment, based on 66 shipments totaling $3.3M. The largest destination is SUDAN (19.9% of Haffkine Bio Pharmaceutical Corporation Limited's Vaccine exports).
How Does Haffkine Bio Pharmaceutical Corporation Limited Compare to Other Indian Vaccine Exporters?
Haffkine Bio Pharmaceutical Corporation Limited ranks #8 among 325 Indian Vaccine exporters with a 0.5% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Haffkine Bio Pharmaceutical Corporation Limited processed 66 shipments to 21 destination countries.
What Vaccine Formulations Does Haffkine Bio Pharmaceutical Corporation Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ORAL POLIO VACCINE (BI-VALENT), ITEM COD | $1.3M | 30 |
| ORAL POLIO VACCINE BI VALENT ITEM CODE 00010 S359190 LIVE ORAL SABIN STRAINBI VALENT READY FOR USE IN VIALS OF 20 | $392.2K | 8 |
| ORAL POLIO VACCINE BI-VALENT ITEM COD | $300.0K | 6 |
| ORAL POLIO VACCINE (BI-VALENT),ITEM CODE | $200.0K | 4 |
| ORAL POLIO VACCINE BI-VALENTITEM CODE | $100.0K | 2 |
| ORAL POLIO VACCINE (BI-VALENT) ITEM CODE 00010 S359190 LIVE ORAL SABIN STRAINBI-VALENT READY FOR USE IN VIALS OF 20NOS | $54.5K | 3 |
| ORAL POLIO VACCINE (BI-VALENT), Material | $50.0K | 1 |
| ORAL POLIO VACCINE BI VALENT MaterialDescription S359190 LIVE ORAL SABIN STRAIN BI VALENT READY FOR USE IN VIALS O | $50.0K | 1 |
| ORAL POLIO VACCINE BI VALENT ITEM CODE00010 S359190 TO 00090 S359190 LIVE ORAL SABIN STRAIN BI VALENT READY FOR USE | $50.0K | 1 |
| ORAL POLIO VACCINE BI VALENT MaterialDescription S359190 LIVE ORAL SABIN STRAIN BI VALENT READY FOR USE IN VIALS OF | $50.0K | 1 |
Haffkine Bio Pharmaceutical Corporation Limited exports 17 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ORAL POLIO VACCINE (BI-VALENT), ITEM COD with 30 shipments worth $1.3M.
How Does Haffkine Bio Pharmaceutical Corporation Limited Compare to Nearest Vaccine Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | HESTER BIOSCIENCES LIMITED | $5.3M | 681 | 25 | $7.8K |
| 12 | ZYDUS LIFESCIENCES LIMITED | $4.5M | 90 | 16 | $50.0K |
| 8 | HAFFKINE BIO PHARMACEUTICAL CORPORATION LIMITED ★ | $3.3M | 66 | 21 | $50.0K |
| 7 | SANOFI HEALTHCARE INDIA PRIVATE LIMITED | $3.0M | 60 | 21 | $50.0K |
| 14 | BIOLOGICAL E LTD | $2.3M | 46 | 25 | $50.0K |
Haffkine Bio Pharmaceutical Corporation Limited ranks #8 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are HESTER BIOSCIENCES LIMITED and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Vaccine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Haffkine Bio Pharmaceutical Corporation Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 66 individual customs records matching Haffkine Bio Pharmaceutical Corporation Limited exporting Vaccine, covering 17 formulations to 21 countries via 29 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Export Data from Haffkine Bio Pharmaceutical Corporation Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Haffkine Bio Pharmaceutical Corporation Limited's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Haffkine Bio Pharmaceutical Corporation Limited
Company Profile
0 products · $0 total trade · 0 categories
Vaccine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Haffkine Bio Pharmaceutical Corporation Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.